Vascular endothelial growth factor expression in head and neck squamous cell carcinoma

American Journal of Surgery

Volumn 174, Issue 5, 1997, Pages 513-517

  Eisma, Roselle J ^a   Spiro, Jeffrey D ^a   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030680070     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00166-9     Document Type: Article

References (11)

1. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Breast Can Res Treat. 1994:85:1045-1049.
2. Havta E, Kaipainen A, Metula P, et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Path. 1995;146:368-378.
3. Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor carcinoma. Cancer. 1996;77:858-863.
4. Senger DR, Van De Water L, Brown LE, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metas Rev. 1993;12:303-324.
5. Claffey KP, Wilkinson WO, Spiegelman BM. Vascular endothelial growth factor. J Bio Chem. 1992:267:16317-16322.
6. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhiol Laryngol. 1995;104:724-729.
7. Albo D, Granick MS, Jhala N, et al. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg. 1995;32:588-594.
8. Gleich LL, Biddinger PW, Pavelic ZP, Gluchman JL. Tumor angiogenesis in T1 oral cavity squamous ell carcinoma: role in predicting tumor aggressiveness. Head Neck. 1996;18:343-346.
9. Cohen RF, Contrino J, Spiro JD, et al. lnterleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolarygol Head Neck Surg. 1995;127:202-209.
10. Berger DP, Herbstrilt L, Dengler WA, et al. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Ann Oncol. 1995;6:817-825.
11. Ben-Av P, Crofford LJ, Wilder RL, Kla T. Induction of vascular endothlial growth factor expression in synovial fobroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995;372:83-87.